Plasma biomarkers of Alzheimer's disease and related dementias in American Indians : The Strong Heart Study
Abstract INTRODUCTION Identification of Alzheimer's disease (AD) needs inexpensive, noninvasive biomarkers, with validation in all populations. METHODS We collected plasma markers in older American Indian individuals: phosphorylated‐tau181 (pTau181); amyloid‐beta (Aβ) 40,42; glial fibrillary acidic protein (GFAP); and neurofilament light chain (NfL). Plasma markers were analyzed for discriminant properties with cognitive status and etiology using receiver operating characteristic (ROC) analysis. RESULTS PTau181, GFAP, NfL plasma values were significantly associated with cognition, but Aβ were not. Discriminant performance was moderate for individual markers, with pTau181, GFAP, NfL performing best, but an empirically selected panel of markers (age, sex, education, pTau181, GFAP, NfL, Aβ4240 ratio) had excellent discriminant performance (AUC > 0.8). DISCUSSION In American Indian individuals, pTau181 and Aβ values suggested more common pathology than in majority populations. Aβ was less informative than in other populations; however, all four markers were needed for a best‐performing dementia diagnostic model. These data validate utility of AD plasma markers, while suggesting population‐specific diagnostic characteristics..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Alzheimer's & Dementia - 20(2024), 3, Seite 2072-2079 |
| Beteiligte Personen: |
Suchy‐Dicey, Astrid M. [VerfasserIn] |
|---|
| Anmerkungen: |
© 2024 the Alzheimer's Association. |
|---|
| Umfang: |
8 |
|---|
| doi: |
10.1002/alz.13664 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY017131669 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY017131669 | ||
| 003 | DE-627 | ||
| 005 | 20240422153701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240422s2024 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/alz.13664 |2 doi | |
| 028 | 5 | 2 | |a 2024-04-22_ALZ_2024_20_3.zip.xml |
| 035 | |a (DE-627)WLY017131669 | ||
| 035 | |a (WILEY)ALZ13664 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Suchy‐Dicey, Astrid M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Plasma biomarkers of Alzheimer's disease and related dementias in American Indians |b The Strong Heart Study |
| 264 | 1 | |c 2024 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2024 the Alzheimer's Association. | ||
| 520 | |a Abstract INTRODUCTION Identification of Alzheimer's disease (AD) needs inexpensive, noninvasive biomarkers, with validation in all populations. METHODS We collected plasma markers in older American Indian individuals: phosphorylated‐tau181 (pTau181); amyloid‐beta (Aβ) 40,42; glial fibrillary acidic protein (GFAP); and neurofilament light chain (NfL). Plasma markers were analyzed for discriminant properties with cognitive status and etiology using receiver operating characteristic (ROC) analysis. RESULTS PTau181, GFAP, NfL plasma values were significantly associated with cognition, but Aβ were not. Discriminant performance was moderate for individual markers, with pTau181, GFAP, NfL performing best, but an empirically selected panel of markers (age, sex, education, pTau181, GFAP, NfL, Aβ4240 ratio) had excellent discriminant performance (AUC > 0.8). DISCUSSION In American Indian individuals, pTau181 and Aβ values suggested more common pathology than in majority populations. Aβ was less informative than in other populations; however, all four markers were needed for a best‐performing dementia diagnostic model. These data validate utility of AD plasma markers, while suggesting population‐specific diagnostic characteristics. | ||
| 700 | 1 | |a Longstreth, W. T. Jr |4 aut | |
| 700 | 1 | |a Rhoads, Kristoffer |4 aut | |
| 700 | 1 | |a Umans, Jason |4 aut | |
| 700 | 1 | |a Buchwald, Dedra |4 aut | |
| 700 | 1 | |a Grabowski, Thomas |4 aut | |
| 700 | 1 | |a Blennow, Kaj |4 aut | |
| 700 | 1 | |a Reiman, Eric |4 aut | |
| 700 | 1 | |a Zetterberg, Henrik |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alzheimer's & Dementia |g 20(2024), 3, Seite 2072-2079 |w (DE-627)WLY001259474 |x 15525279 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2024 |g number:3 |g pages:2072-2079 |g extent:8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2024 |e 3 |h 2072-2079 |g 8 | ||